-
Sara R. Collins
Senior Scholar, Vice President, Health Care Coverage and Access & Tracking Health System Performance, The Commonwealth Fund
-
Karen Davis
Professor Emerita in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
-
Kevin Lucia
Research Professor, Center on Health Insurance Reforms, Health Policy Institute, McCourt School of Public Policy, Georgetown University
Showing 514 - 522 of 571 Results
Issue Briefs / Sep 27, 2017
Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending?blog / Feb 07, 2022
Overdose Deaths Surged in the First Half of 2021, Underscoring Urgent Need for ActionIssue Briefs / Sep 22, 2022
The New Gold Standard: How Changing the Marketplace Coverage Benchmark Could Impact AffordabilityIssue Briefs / Jul 20, 2022
The Impact of Pharmaceutical Wholesalers on U.S. Drug SpendingIssue Briefs / Mar 26, 2019
Pharmacy Benefit Managers: Practices, Controversies, and What Lies AheadIssue Briefs / Aug 30, 2019
Reducing Wasteful Spending in Employers’ Pharmacy Benefit PlansIssue Briefs / Aug 05, 2020
Telemedicine: What Should the Post-Pandemic Regulatory and Payment Landscape Look Like?